In persons exposed to influenza, zanamivir, oseltamivir, laninamivir, and baloxavir reduce symptomatic seasonal influenza

Ann Intern Med. 2024 Dec;177(12):JC134. doi: 10.7326/ANNALS-24-03197-JC. Epub 2024 Dec 3.

Abstract

Zhao Y, Gao Y, Guyatt G, et al. Antivirals for post-exposure prophylaxis of influenza: a systematic review and network meta-analysis. Lancet. 2024;404:764-772. 39181596.

MeSH terms

  • Antiviral Agents* / therapeutic use
  • Dibenzothiepins* / therapeutic use
  • Guanidines / therapeutic use
  • Humans
  • Influenza, Human* / drug therapy
  • Influenza, Human* / prevention & control
  • Morpholines / adverse effects
  • Morpholines / therapeutic use
  • Network Meta-Analysis
  • Oseltamivir* / therapeutic use
  • Oxazines / therapeutic use
  • Post-Exposure Prophylaxis* / methods
  • Pyrans / therapeutic use
  • Pyrazines / adverse effects
  • Pyrazines / therapeutic use
  • Pyridones / therapeutic use
  • Seasons
  • Systematic Reviews as Topic
  • Thiepins / therapeutic use
  • Triazines* / adverse effects
  • Triazines* / therapeutic use
  • Zanamivir* / therapeutic use

Substances

  • Antiviral Agents
  • baloxavir
  • Dibenzothiepins
  • Guanidines
  • laninamivir
  • Morpholines
  • Oseltamivir
  • Oxazines
  • Pyrans
  • Pyrazines
  • Pyridones
  • Thiepins
  • Triazines
  • Zanamivir